This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview
Mulero Sanchez, Antonio

Antonio Mulero Sanchez



In September 2016 I obtained my MSc degree in Translational Biomedicine at the university of Barcelona (Spain), during the master thesis I moved to Amsterdam to do the internship in the Netherlands Cancer Institute (NKI).

Currently, I am continuing the project I started during my master's in the group of professor René Benards as a Technician. The project I am developing is based on the role of PTPN11/SHP2 in different K-Ras mutant cancers.  K-ras is commonly mutated in different cancers as colon, lung and pancreas. In order to find out a new and better treatment, we are working to see if there is synthetic lethal interaction between MEK inhibitor and a novel small molecule targeting SHP2 protein.